NCT07621523 Energy Cost and Metabolic Intensity of Pilates Exercises in Older Adults
| NCT ID | NCT07621523 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidade Estadual do Norte do Parana |
| Condition | Energy Metabolism |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-06 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-06 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pilates is one of the most popular forms of exercise among older adults worldwide. However, no study has measured how many calories a Pilates session burns or how hard the body works during it in people aged 60 and over. This information is important for exercise professionals who prescribe Pilates for health promotion goals such as weight management and cardiovascular fitness. This study will measure the energy cost and metabolic intensity of two types of Pilates - mat Pilates and equipment-based Pilates - in older adults using a portable indirect calorimetry system (Cosmed K5). Results will be compared to treadmill walking at 4.8 km/h, a well-established moderate-intensity activity. Twenty men and women aged 60 years or older with at least 6 months of continuous Pilates experience will complete three exercise sessions in a randomized order: (1) mat Pilates, (2) equipment-based Pilates, and (3) treadmill walking. Each Pilates session will consist of 9 exercises, with stretching exercises used as warm-up and cool-down and 7 strengthening exercises performed in the main portion of the session (\~50 min). Oxygen consumption, energy expenditure, heart rate, and perceived exertion will be measured throughout each session.
Eligibility Criteria
Inclusion Criteria: * Age 60 years or older; * Body mass index (BMI) between 22 and 27 kg/m²; * Not currently undergoing dietary treatment or program for weight gain or loss; * No severe musculoskeletal disorders (e.g., osteoarthritis grade III or IV, moderate-to-severe pain ≥ 4 on the NRS 0-10 scale) or neurological conditions (e.g., Parkinson's disease, Alzheimer's disease, multiple sclerosis); * Continuously practicing Pilates for at least 6 months prior to enrollment, with a minimum frequency of twice per week. Exclusion Criteria: * Chronic decompensated conditions that may pose health risks during exercise (e.g., uncontrolled hypertension, bronchitis, asthma); * Any history of cardiovascular events (e.g., coronary artery disease, stroke, heart failure, arrhythmias, valvular heart disease); * Decompensated metabolic diseases or use of medications with recognized direct impact on energy and glycemic metabolism, including antidiabetics and systemic corticosteroids; * Positive response to any item on the Physical Activity Readiness Questionnaire (PAR-Q).
Contact & Investigator
Matheus R Quaglio, MSC
STUDY CHAIR
Universidade Estadual do Norte do Paraná
Frequently Asked Questions
Who can join the NCT07621523 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Energy Metabolism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07621523 currently recruiting?
Yes, NCT07621523 is actively recruiting participants. Contact the research team at rgoliveira@uenp.edu.br for enrollment information.
Where is the NCT07621523 trial being conducted?
This trial is being conducted at Jacarezinho, Brazil.
Who is sponsoring the NCT07621523 clinical trial?
NCT07621523 is sponsored by Universidade Estadual do Norte do Parana. The principal investigator is Matheus R Quaglio, MSC at Universidade Estadual do Norte do Paraná. The trial plans to enroll 20 participants.